ORBITAL APEX SYNDROME

ORBITAL APEX SYNDROME was reported 83 times

ORBITAL APEX SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 9 0.0004
1 Prostaglandin E1 Analog [EPC] 2 0.0001
2 Penem Antibacterial [EPC] 4 0.0001
3 Lipid-based Polyene Antifungal [EPC] 1 0.0001
4 Azole Antifungal [EPC] 12 0.0001
5 Glycopeptide Antibacterial [EPC] 4 0.0001
6 Human Immunoglobulin G [EPC] 1 0.0000
7 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
8 Alkylating Drug [EPC] 11 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
10 Antimycobacterial [EPC] 1 0.0000
11 Nucleoside Analog Antiviral [EPC] 3 0.0000
12 Iron Chelator [EPC] 1 0.0000
13 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
14 Rifamycin Antibacterial [EPC] 1 0.0000
15 Corticosteroid [EPC] 35 0.0000
16 Janus Kinase Inhibitor [EPC] 4 0.0000
17 Polyene Antifungal [EPC] 1 0.0000
18 Amide Local Anesthetic [EPC] 2 0.0000
19 Aminosalicylate [EPC] 2 0.0000
20 CD20-directed Cytolytic Antibody [EPC] 6 0.0000
21 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
22 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
23 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
24 Sulfonylurea [EPC] 2 0.0000
25 Fluoroquinolone Antibacterial [EPC] 2 0.0000
26 Kinase Inhibitor [EPC] 8 0.0000
27 Tumor Necrosis Factor Blocker [EPC] 14 0.0000
28 Loop Diuretic [EPC] 5 0.0000
29 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 5 0.0000
31 Proton Pump Inhibitor [EPC] 5 0.0000
32 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
33 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000